Search research articles
Contact Us
Filters
Showing results (1-10 of 123) with videos related to
Page
of 13
Sort By:
Radiologic Clinics of North America
|
July 16, 2002
Breast imaging: a breast surgeon's perspective
Kimberly J Van Zee
Annals of Surgical Oncology
|
August 25, 2019
ASO Author Reflections: Does Genomic Testing of DCIS Provide Added Value? And Is It Worth the Cost?
Kimberly J Van Zee
JAMA Oncology
|
July 17, 2015
Use of Axillary Staging in the Management of Ductal Carcinoma In Situ
Kimberly J Van Zee
Annals of Surgical Oncology
|
May 12, 2016
Margins in DCIS: Does Residual Disease Provide an Answer?
Monica Morrow, Kimberly J Van Zee
Current Breast Cancer Reports
|
February 8, 2021
Treatment of Ductal Carcinoma in Situ: Considerations for Tailoring Therapy in the Contemporary Era
Anita Mamtani, Kimberly J Van Zee
Annals of Surgical Oncology
|
September 25, 2019
ASO Author Reflections: Advising a Woman with Ductal Carcinoma In Situ Regarding Various Treatment Options-A Complex Decision
Anita Mamtani, Kimberly J Van Zee
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 25, 2012
Validation of a nomogram for predicting risk of local recurrence for ductal carcinoma in situ
Kimberly J Van Zee, Sujata Patil
Annals of Surgical Oncology
|
September 2, 2008
Predicting nonsentinel node metastases in sentinel node-positive breast cancer: what have we learned, can we do better, and do we need to?
Hiram S Cody, Kimberly J Van Zee
Annals of Surgical Oncology
|
May 18, 2007
Validating a predictive model for presence of additional disease in the non-sentinel lymph nodes of a woman with sentinel node positive breast cancer
Kimberly J Van Zee, Michael W Kattan
The New England Journal of Medicine
|
August 6, 2015
Reexcision--The Other Breast Cancer Epidemic
Hiram S Cody, Kimberly J Van Zee
Page
of 13
Search research articles
Search
Showing results (1-10 of 123) with videos related to
Sort By:
Page
of 13
Radiologic Clinics of North America
|
July 16, 2002
Breast imaging: a breast surgeon's perspective
Kimberly J Van Zee
Annals of Surgical Oncology
|
August 25, 2019
ASO Author Reflections: Does Genomic Testing of DCIS Provide Added Value? And Is It Worth the Cost?
Kimberly J Van Zee
JAMA Oncology
|
July 17, 2015
Use of Axillary Staging in the Management of Ductal Carcinoma In Situ
Kimberly J Van Zee
Annals of Surgical Oncology
|
May 12, 2016
Margins in DCIS: Does Residual Disease Provide an Answer?
Monica Morrow, Kimberly J Van Zee
Current Breast Cancer Reports
|
February 8, 2021
Treatment of Ductal Carcinoma in Situ: Considerations for Tailoring Therapy in the Contemporary Era
Anita Mamtani, Kimberly J Van Zee
Annals of Surgical Oncology
|
September 25, 2019
ASO Author Reflections: Advising a Woman with Ductal Carcinoma In Situ Regarding Various Treatment Options-A Complex Decision
Anita Mamtani, Kimberly J Van Zee
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 25, 2012
Validation of a nomogram for predicting risk of local recurrence for ductal carcinoma in situ
Kimberly J Van Zee, Sujata Patil
Annals of Surgical Oncology
|
September 2, 2008
Predicting nonsentinel node metastases in sentinel node-positive breast cancer: what have we learned, can we do better, and do we need to?
Hiram S Cody, Kimberly J Van Zee
Annals of Surgical Oncology
|
May 18, 2007
Validating a predictive model for presence of additional disease in the non-sentinel lymph nodes of a woman with sentinel node positive breast cancer
Kimberly J Van Zee, Michael W Kattan
The New England Journal of Medicine
|
August 6, 2015
Reexcision--The Other Breast Cancer Epidemic
Hiram S Cody, Kimberly J Van Zee
Page
of 13